RX658 RX658 RX658 RX658
Pill imprint RX658 RX658 RX658 RX658 has been identified as Cefaclor 250 mg.
Cefaclor is used in the treatment of upper respiratory tract infection; urinary tract infection; bladder infection; sinusitis; kidney infections (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy.
Cefaclor 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Cefaclor Images
- Imprint:
-
RX658 RX658
RX658 RX658 - Strength:
- 250 mg
- Color:
- Blue / White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
croscarmellose sodium
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
gelatin
magnesium stearate
pregelatinized starch
titanium dioxide
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- 63304-0658
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66267-0262 | Nucare Pharmaceuticals Inc (repackager) |
| 68115-0065 | Dispensexpress Inc (repackager) |
| 63874-0119 | Altura Pharmaceuticals Inc (repackager) |
| 66336-0202 | Dispensing Solutions Inc. (repackager) |
| 16590-0041 | Stat RX USA LLC (repackager) |
| 23490-5218 | Palmetto State Pharmaceuticals Inc (repackager) |
| 33358-0065 | Core Pharmaceuticals Inc (repackager) |
| 53002-0211 | Pharmedix (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Cefaclor resources
- Cefaclor (Wolters Kluwer)
- Cefaclor Capsules (Wolters Kluwer)
- Cefaclor Extended-Release Tablets (Wolters Kluwer)
- Cefaclor Suspension (Wolters Kluwer)
- cefaclor (Cerner Multum)
- Cefaclor (AHFS DI)
- Cefaclor Capsules (FDA)
- Cefaclor Extended Release Tablets (FDA)
- cefaclor (FDA)
- Cefaclor (Wolters Kluwer)
Search Again
